These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 6368589)

  • 21. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells.
    Moscatelli D
    J Cell Biochem; 1986; 30(1):19-29. PubMed ID: 3082899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin.
    Rao JS; Baker JB; Morantz RA; Kimler B; Evans R; Festoff BW
    Cancer Res; 1990 Aug; 50(16):5039-44. PubMed ID: 2116223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
    Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
    Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elastin degradation by mononuclear phagocytes.
    Shapiro SD; Campbell EJ; Welgus HG; Senior RM
    Ann N Y Acad Sci; 1991; 624():69-80. PubMed ID: 2064250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
    Lijnen HR; Wagner EF; Collen D
    Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.
    Kroon ME; Koolwijk P; van Goor H; Weidle UH; Collen A; van der Pluijm G; van Hinsbergh VW
    Am J Pathol; 1999 Jun; 154(6):1731-42. PubMed ID: 10362798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of plasminogen activator by alveolar macrophages in normal subjects and patients with interstitial lung disease.
    Robinson BW
    Thorax; 1988 Jul; 43(7):508-15. PubMed ID: 3212749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
    Vassalli JD; Dayer JM; Wohlwend A; Belin D
    J Exp Med; 1984 Jun; 159(6):1653-68. PubMed ID: 6374011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrin activatable urokinase (FA-UK): a latent form of UK found in urine related to a complex with an inhibitor/fibrin-interacting cofactor.
    Dwivedi C; Pannell R; Gurewich V
    Thromb Res; 1988 Jul; 51(2):197-208. PubMed ID: 3055414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages.
    Werb Z; Banda MJ; Jones PA
    J Exp Med; 1980 Nov; 152(5):1340-57. PubMed ID: 7000966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase.
    Gross TJ; Simon RH; Kelly CJ; Sitrin RG
    Am J Physiol; 1991 Apr; 260(4 Pt 1):L286-95. PubMed ID: 1902065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrilysin-dependent elastolysis by human macrophages.
    Filippov S; Caras I; Murray R; Matrisian LM; Chapman HA; Shapiro S; Weiss SJ
    J Exp Med; 2003 Sep; 198(6):925-35. PubMed ID: 12963695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the catalytic activity of plasminogen activator under physiologic conditions.
    Aggeler J; Risch J; Werb Z
    Biochim Biophys Acta; 1981 Jun; 675(1):62-8. PubMed ID: 6455162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease.
    Chapman HA; Allen CL; Stone OL
    Am Rev Respir Dis; 1986 Mar; 133(3):437-43. PubMed ID: 3954252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of plasminogen activator from two human renal carcinoma cell lines.
    Nelson NF; Cieplak W; Dacus SC; Prager MD
    J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen activation in healing human wounds.
    Schäfer BM; Maier K; Eickhoff U; Todd RF; Kramer MD
    Am J Pathol; 1994 Jun; 144(6):1269-80. PubMed ID: 8203466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The distribution of procoagulant and plasminogen activator activities among density fractions of normal rabbit alveolar macrophages.
    Sitrin RG; Brubaker PG; Shellito JE; Kaltreider HB
    Am Rev Respir Dis; 1986 Mar; 133(3):468-72. PubMed ID: 3954254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.